Utility of social media and crowd-sourced data for pharmacovigilance
Tricco AC, Zarin W, Lillie E, Jeblee S, Warren R, Khan PA, Robson R, Pham B, Hirst G, Straus SE. Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. BMC Med Inform Decis Mak. 2018 Jun 14;18(1):38. doi: 10.1186/s12911-018-0621-y.
[sidebar]
Commissioner: Health Canada
Funder: Canadian Institutes of Health Research (CIHR) through the Drug Safety and Effectiveness Network (DSEN)
Share Buttons [span][/span]
[ssba-buttons] [/sidebar] [sidebar-content]- Conducted for Health Canada to provide information on the validity and reliability of using social media data for pharmacovigilance to inform conceptualization of a potential social media listening platform for drug-safety surveillance in Canada
- Results suggest that the use of social media data for pharmacovigilance is in its infancy
- Social media has the potential to supplement data from regulatory agency databases; capturing less frequently reported adverse events and identifying adverse events earlier than official alerts or labeling revision time, however, the utility and validity of the data sources remain under-studied
Almetrics:
[/sidebar-content]Category : KS Projects
Date : 18 Dec 2019